"Second cancer" trang 1 - tải miễn phí từ tailieunhanh
Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: A nationwide survey in Korea

Mode of primary cancer detection as an indicator of screening practice for second primary cancer in cancer survivors: A nationwide survey in Korea
9    60    1
Risk of second primary Cancer among bladder Cancer patients: A populationbased cohort study in Korea

Risk of second primary Cancer among bladder Cancer patients: A populationbased cohort study in Korea
9    86    1
Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: A systematic literature review and metaanalysis

Single nucleotide polymorphisms and the risk of developing a second primary cancer among head and neck cancer patients: A systematic literature review and metaanalysis
24    36    1
Second primary colorectal cancer after the initial primary colorectal cancer

Second primary colorectal cancer after the initial primary colorectal cancer
9    68    1
Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: A retrospective study

Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: A retrospective study
8    96    1
Second primary cancer risk - the impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study

Second primary cancer risk - the impact of applying different definitions of multiple primaries: Results from a retrospective population-based cancer registry study
11    65    1
Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: A population-based study

Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: A population-based study
14    134    1
Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer

Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nabpaclitaxel therapy in metastatic pancreatic cancer
9    77    0
Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development

Differences in colonic crypt morphology of spontaneous and colitis-associated murine models via second harmonic generation imaging to quantify colon cancer development
11    72    0
Risk of second primary cancers in cancer patients treated with cisplatin: A systematic review and meta-analysis of randomized studies

Risk of second primary cancers in cancer patients treated with cisplatin: A systematic review and meta-analysis of randomized studies
12    52    1
The relative risk of second primary cancers in Austria’s western states: A retrospective cohort study

The relative risk of second primary cancers in Austria’s western states: A retrospective cohort study
8    55    1
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study

FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
8    52    1
Therapeutic method for early-stage second primary non-small lung cancer: Analysis of a population-based database

Therapeutic method for early-stage second primary non-small lung cancer: Analysis of a population-based database
9    44    1
Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: Study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)
7    1    1
Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: A retrospective cohort analysis

Superiority of NBI endoscopy to PET/CT scan in detecting esophageal cancer among head and neck cancer patients: A retrospective cohort analysis
9    66    1
Colorectal cancer risk in association with colorectal cancer as a second malignancy in relatives: A nationwide cohort study

Colorectal cancer risk in association with colorectal cancer as a second malignancy in relatives: A nationwide cohort study
8    1    1
BREAST CANCER SECOND EDITION

BREAST CANCER SECOND EDITION
567    79    0
Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC)

Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC)
13    86    1
Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck

Site disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck
9    53    1
Vinorelbine as second-line treatment of NSCLC after the failure of platinum-taxane combination at the Hue University hospital

Vinorelbine as second-line treatment of NSCLC after the failure of platinum-taxane combination at the Hue University hospital
5    87    1